Why the study?
Diabetic cardiomyopathy can lead to heart failure, and this study aimed to explore the cardioprotective role and mechanisms of cinnamaldehyde on diabetic cardiomyopathy.
Does cinnamaldehyde attenuate diabetic cardiomyopathy in STZ-induced diabetic rats?
Population
Streptozotocin-induced diabetic rats
Comparison
Cinnamaldehyde (50 mg/kg daily)
Design
Animal experimental study
Follow-up
28 days
Key result
Cinnamaldehyde alleviated diabetic cardiomyopathy in rats by modulating the AMPK-α2/PPAR-α/PGC-1α signaling pathway to restore energy metabolism and activating autophagy through the mTOR pathway.
Authors
Loading...
CA attenuates DCM in STZ rats; hypothesis-generating for human translation.
Does cinnamaldehyde attenuate diabetic cardiomyopathy in STZ-induced diabetic rats?
In a rat model of diabetic cardiomyopathy, cinnamaldehyde attenuated cardiac injury by restoring energy metabolism and activating autophagy.
Hu et al. (2025) studied Diabetic Cardiomyopathy. Cinnamaldehyde was evaluated on Energy metabolism disturbance and autophagy activation. Cinnamaldehyde alleviated diabetic cardiomyopathy in rats by modulating the AMPK-α2/PPAR-α/PGC-1α signaling pathway to restore energy metabolism and activating autophagy through the mTOR pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: